celecoxib has been researched along with sodium glutamate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cecchini, R; Cunha, NV; de Abreu, SB; Grassiolli, S; Guarnier, FA; Martins-Pinge, MC; Mazzuco, TL; Panis, C; Pinge-Filho, P | 1 |
| Barbosa Neto, O; da Cunha, NV; Grassiolli, S; Martins-Pinge, MC; Pinge-Filho, P | 1 |
2 other study(ies) available for celecoxib and sodium glutamate
| Article | Year |
|---|---|
Cox-2 inhibition attenuates cardiovascular and inflammatory aspects in monosodium glutamate-induced obese rats.
Topics: Adipose Tissue; Animals; Blood; Blood Pressure; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Heart; Heart Rate; Hypertension; Inflammation; Lipid Peroxidation; Lipid Peroxides; Liver; Male; Myocardium; Nitrates; Obesity; Pyrazoles; Rats; Rats, Wistar; Sodium Glutamate; Sulfonamides | 2010 |
COX-2 inhibition does not reverse the increased sympathetic modulation in MSG obese rats.
Topics: Animals; Blood Pressure; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Food Additives; Heart Rate; Male; Obesity; Pyrazoles; Rats; Rats, Wistar; Sodium Glutamate; Sulfonamides; Sympathetic Nervous System | 2011 |